ChemicalBook >> CAS DataBase List >>Sonelokimab

Sonelokimab

CAS No.
1414386-05-2
Chemical Name:
Sonelokimab
Synonyms
Sonelokimab;Research Grade Sonelokimab;Research Grade Sonelokimab(DHH28808)
CBNumber:
CB28081191
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-04-24 14:59:02

Sonelokimab Properties

form Liquid
color Colorless to light yellow
FDA UNII LEN0OCZ4SH

Sonelokimab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0624046 Sonelokimab 99.81% 1414386-05-2 1mg $704 2026-06-04 Buy
ChemScene CS-0624046 Sonelokimab 99.81% 1414386-05-2 5mg $1842 2026-06-04 Buy
ChemScene CS-0624046 Sonelokimab 99.81% 1414386-05-2 10mg $2925 2026-06-04 Buy
aablocks AA029Z53 Sonelokimab >98% 1414386-05-2 1mg $758 2026-06-02 Buy
aablocks AA029Z53 Sonelokimab >98% 1414386-05-2 5mg $1924 2026-06-02 Buy
Product number Packaging Price Buy
CS-0624046 1mg $704 Buy
CS-0624046 5mg $1842 Buy
CS-0624046 10mg $2925 Buy
AA029Z53 1mg $758 Buy
AA029Z53 5mg $1924 Buy

Sonelokimab Chemical Properties, Uses, Production

Uses

Sonelokimab (ALX 0761) is a trivalent bispecific nanobody composed of camel derived humanized IL-17F antibodies, IL-17A/F antibodies, and serum albumin VHH antibodies. Sonelokimab can prolong the plasma half-life by binding to human serum albumin. Sonelokimab can be used for research on rheumatoid arthritis and psoriasis[1][2][3][4].

in vivo

Sonelokimab (2.8 and 10 mg/kg, s.c., weekly intervals for 8 consecutive weeks) reduces IL-15, IL-6, MMP-3 and TNF-α expression and demonstrates the potential preventive effect of arthritis in a collagen-induced arthritis model in cynomolgus monkey[4].

Animal Model:A collagen-induced arthritis model in cynomolgus monkey[4]
Dosage:2.8 and 10 mg/kg
Administration:weekly intervals for 8 consecutive weeks
Result:Significantly improved X-ray score B and the arthritis score in a collagen-induced arthritis model in cynomolgus monkey.

IC 50

IL-17A; IL-17F

References

[1] Torres T, et al. A revolutionary therapeutic approach for psoriasis: bispecific biological agents. Expert Opin Investig Drugs. 2016 Jul;25(7):751-4. DOI:10.1080/13543784.2016.1187130
[2] Rossotti MA, et al. Immunogenicity and humanization of single-domain antibodies. FEBS J. 2022 Jul;289(14):4304-4327. DOI:10.1111/febs.15809
[3] Gao W, et al. Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis. Front Immunol. 2023 May 25;14:1151977. DOI:10.3389/fimmu.2023.1151977
[4] Vanheusden K, et al. Pre-clinical proof-of-concept of ALX-0761, a Nanobody neutralizing both IL-17A and F in a cynomolgus monkey collagen induced arthritis model[C]//ARTHRITIS AND RHEUMATISM. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: Wiley-Blackwell, 2013, 65: S543-S543.

Sonelokimab Preparation Products And Raw materials

Raw materials

Preparation Products

Sonelokimab Suppliers

Global Suppliers ( 15)
Supplier Tel Email Country ProdList Advantage
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10305 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 psaitong@jm-bio.com China 27626 58
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9864 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 7283 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Atagenix Laboratories 027-87008169 17762441161 info@atagenix.com China 9997 58
Wuhan Maixi Biotechnology Co., Ltd 18007167883 18007167883 Service@mabnus.com China 921 58
TargetMol 400-821-0310 15002144251 xuexiang.shao@tsbiochem.com China 29128 58
Shanghai Fengyong Biotechnology Co., Ltd. 021-10000000 13000000000 gzj@abmole.cn China 9323 58
Sonelokimab Research Grade Sonelokimab(DHH28808) Research Grade Sonelokimab 1414386-05-2